| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Departments of 1 Molecular Biophysics and Biochemistry, 2 Pathology, 3 Epidemiology, 4 Surgery, 5 Internal Medicine, 6 Dermatology, and 7 Cell Biology, Yale University School of Medicine, New Haven, Connecticut; 8 Division of Regulation of Macromolecular Functions, Institute for Protein Research, Osaka University, Osaka, Japan; and 9 Laboratory Medicine and Pathobiology, Cancer Research Program, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
Affymetrix and spotted oligonucleotide microarrays were used to assess global differential gene expression comparing normal human melanocytes with six independent melanoma cell strains from advanced lesions. The data, validated at the protein level for selected genes, confirmed the overexpression in melanoma cells relative to normal melanocytes of several genes in the growth factor/receptor family that confer growth advantage and metastasis. In addition, novel pathways and patterns of associated expression in melanoma cells not reported before emerged, including the following: (a) activation of the NOTCH pathway; (b) increased Twist expression and altered expression of additional transcriptional regulators implicated in embryonic development and epidermal/mesenchymal transition; (c) coordinated activation of cancer/testis antigens; (d) coordinated down-regulation of several immune modulation genes, in particular in the IFN pathways; (e) down-regulation of several genes implicated in membrane trafficking events; and (f) down-regulation of growth suppressors, such as the Prader-Willi gene NECDIN, whose function was confirmed by overexpression of ectopic Flag-necdin. Validation of differential expression using melanoma tissue microarrays showed that reduced ubiquitin COOH-terminal esterase L1 in primary melanoma is associated with worse outcome and that increased expression of the basic helix-loop-helix protein Twist is associated with worse outcome. Some differentially expressed genes reside on chromosomal regions displaying common loss or gain in melanomas or are known to be regulated by CpG promoter methylation. These results provide a comprehensive view of changes in advanced melanoma relative to normal melanocytes and reveal new targets that can be used in assessing prognosis, staging, and therapy of melanoma patients.
This article has been cited by other articles:
![]() |
G. M. Kreizenbeck, A. J. Berger, A. Subtil, D. L. Rimm, and B. E. Gould Rothberg Prognostic Significance of Cadherin-Based Adhesion Molecules in Cutaneous Malignant Melanoma Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 949 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-M. Postovit, N. V. Margaryan, E. A. Seftor, D. A. Kirschmann, A. Lipavsky, W. W. Wheaton, D. E. Abbott, R. E. B. Seftor, and M. J. C. Hendrix Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells PNAS, March 18, 2008; 105(11): 4329 - 4334. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abrahams, S. Mowla, M. I. Parker, C. R. Goding, and S. Prince UV-mediated Regulation of the Anti-senescence Factor Tbx2 J. Biol. Chem., January 25, 2008; 283(4): 2223 - 2230. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Gajewski, E. A. Grimm, B. J. Nickoloff, and A. T. Weeraratna New Potential Therapeutic Targets in Melanoma ASCO Educational Book, January 1, 2008; 2008(1): 404 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Shah, J. M. Summy, J. Zhang, S. I. Park, N. U. Parikh, and G. E. Gallick Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells Ann. Surg. Oncol., December 1, 2007; 14(12): 3629 - 3637. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Kwok, M.-T. Ling, H. F. Yuen, Y.-C. Wong, and X. Wang Role of p14ARF in TWIST-mediated senescence in prostate epithelial cells Carcinogenesis, December 1, 2007; 28(12): 2467 - 2475. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nambiar, A. Mirmohammadsadegh, M. Hassan, R. Mota, A. Marini, A. Alaoui, A. Tannapfel, J. H. Hegemann, and U. R. Hengge Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance Carcinogenesis, December 1, 2007; 28(12): 2501 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. Lo, S.-C. Hsu, W. Xia, X. Cao, J.-Y. Shih, Y. Wei, J. L. Abbruzzese, G. N. Hortobagyi, and M.-C. Hung Epidermal Growth Factor Receptor Cooperates with Signal Transducer and Activator of Transcription 3 to Induce Epithelial-Mesenchymal Transition in Cancer Cells via Up-regulation of TWIST Gene Expression Cancer Res., October 1, 2007; 67(19): 9066 - 9076. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Watson, L. R. Ylagan, K. M. Trinkaus, W. E. Gillanders, M. J. Naughton, K. N. Weilbaecher, T. P. Fleming, and R. L. Aft Isolation and Molecular Profiling of Bone Marrow Micrometastases Identifies TWIST1 as a Marker of Early Tumor Relapse in Breast Cancer Patients Clin. Cancer Res., September 1, 2007; 13(17): 5001 - 5009. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bolos, J. Grego-Bessa, and J. L. de la Pompa Notch Signaling in Development and Cancer Endocr. Rev., May 1, 2007; 28(3): 339 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-F. Yuen, Y.-P. Chan, M. Lok-Yee Wong, W.-K. Kwok, K.-K. Chan, P.-Y. Lee, G. Srivastava, S. Y.-K. Law, Y.-C. Wong, X. Wang, et al. Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis J. Clin. Pathol., May 1, 2007; 60(5): 510 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Alonso, L. Tracey, P. Ortiz, B. Perez-Gomez, J. Palacios, M. Pollan, J. Linares, S. Serrano, A. I. Saez-Castillo, L. Sanchez, et al. A High-Throughput Study in Melanoma Identifies Epithelial-Mesenchymal Transition as a Major Determinant of Metastasis Cancer Res., April 1, 2007; 67(7): 3450 - 3460. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Z. Cheng, J. Chan, Q. Wang, W. Zhang, C. D. Sun, and L.-H. Wang Twist Transcriptionally Up-regulates AKT2 in Breast Cancer Cells Leading to Increased Migration, Invasion, and Resistance to Paclitaxel Cancer Res., March 1, 2007; 67(5): 1979 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Shields, N. E. Thomas, M. Cregger, A. J. Berger, M. Leslie, C. Torrice, H. Hao, S. Penland, J. Arbiser, G. Scott, et al. Lack of Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Signaling Shows a New Type of Melanoma Cancer Res., February 15, 2007; 67(4): 1502 - 1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ghajar, V. Suresh, S. R. Peyton, C. B. Raub, F. L. Meyskens Jr., S. C. George, and A. J. Putnam A novel three-dimensional model to quantify metastatic melanoma invasion Mol. Cancer Ther., February 1, 2007; 6(2): 552 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Seliger, A. Fedorushchenko, W. Brenner, A. Ackermann, D. Atkins, S. Hanash, and R. Lichtenfels Ubiquitin COOH-Terminal Hydrolase 1: A Biomarker of Renal Cell Carcinoma Associated with Enhanced Tumor Cell Proliferation and Migration[?Q1: Running head: UCHL1, a Biomarker of RCC. Short title OK?Q1] Clin. Cancer Res., January 1, 2007; 13(1): 27 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Lee, R. T.P. Poon, A. P. Yuen, M. T. Ling, W. K. Kwok, X. H. Wang, Y. C. Wong, X. Y. Guan, K. Man, K. L. Chau, et al. Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition. Clin. Cancer Res., September 15, 2006; 12(18): 5369 - 5376. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Packer, S. Pavey, A. Parker, M. Stark, P. Johansson, B. Clarke, P. Pollock, M. Ringner, and N. Hayward Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN Carcinogenesis, September 1, 2006; 27(9): 1778 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-M. Postovit, E. A. Seftor, R. E.B. Seftor, and M. J.C. Hendrix Influence of the Microenvironment on Melanoma Cell Fate Determination and Phenotype Cancer Res., August 15, 2006; 66(16): 7833 - 7836. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. R. Bhat, N. Maddodi, C. Shashikant, and V. Setaluri Transcriptional regulation of human MAP2 gene in melanoma: role of neuronal bHLH factors and Notch1 signaling Nucleic Acids Res., August 11, 2006; 34(13): 3819 - 3832. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Reu, S. I. Bae, L. Cherkassky, D. W. Leaman, D. Lindner, N. Beaulieu, A. R. MacLeod, and E. C. Borden Overcoming Resistance to Interferon-Induced Apoptosis of Renal Carcinoma and Melanoma Cells by DNA Demethylation J. Clin. Oncol., August 10, 2006; 24(23): 3771 - 3779. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Bauer, P J Wild, S Meyer, F Bataille, A Pauer, M Klinkhammer-Schalke, F Hofstaedter, and A K Bosserhoff Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays J. Clin. Pathol., July 1, 2006; 59(7): 699 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. McCarthy, K. A. DiVito, M. Sznol, D. Kovacs, R. Halaban, A. J. Berger, K. T. Flaherty, R. L. Camp, R. Lazova, D. L. Rimm, et al. Expression of tumor necrosis factor-related apoptosis-inducing ligand receptors 1 and 2 in melanoma. Clin. Cancer Res., June 15, 2006; 12(12): 3856 - 3863. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, S. A. Mani, and R. A. Weinberg Exploring a New Twist on Tumor Metastasis. Cancer Res., May 1, 2006; 66(9): 4549 - 4552. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-J. Liu, M. Xiao, K. Balint, K. S.M. Smalley, P. Brafford, R. Qiu, C. C. Pinnix, X. Li, and M. Herlyn Notch1 Signaling Promotes Primary Melanoma Progression by Activating Mitogen-Activated Protein Kinase/Phosphatidylinositol 3-Kinase-Akt Pathways and Up-regulating N-Cadherin Expression. Cancer Res., April 15, 2006; 66(8): 4182 - 4190. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Winnepenninckx, V. Lazar, S. Michiels, P. Dessen, M. Stas, S. R. Alonso, M.-F. Avril, P. L. Ortiz Romero, T. Robert, O. Balacescu, et al. Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst, April 5, 2006; 98(7): 472 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Seftor, K. M. Brown, L. Chin, D. A. Kirschmann, W. W. Wheaton, A. Protopopov, B. Feng, Y. Balagurunathan, J. M. Trent, B. J. Nickoloff, et al. Epigenetic Transdifferentiation of Normal Melanocytes by a Metastatic Melanoma Microenvironment Cancer Res., November 15, 2005; 65(22): 10164 - 10169. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Gure, R. Chua, B. Williamson, M. Gonen, C. A. Ferrera, S. Gnjatic, G. Ritter, A. J.G. Simpson, Y.-T. Chen, L. J. Old, et al. Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non-Small Cell Lung Cancer Clin. Cancer Res., November 15, 2005; 11(22): 8055 - 8062. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Talantov, A. Mazumder, J. X. Yu, T. Briggs, Y. Jiang, J. Backus, D. Atkins, and Y. Wang Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions Clin. Cancer Res., October 15, 2005; 11(20): 7234 - 7242. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Kwok, M.-T. Ling, T.-W. Lee, T. C.M. Lau, C. Zhou, X. Zhang, C. W. Chua, K. W. Chan, F. L. Chan, C. Glackin, et al. Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target Cancer Res., June 15, 2005; 65(12): 5153 - 5162. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Vance, S. Carreira, G. Brosch, and C. R. Goding Tbx2 Is Overexpressed and Plays an Important Role in Maintaining Proliferation and Suppression of Senescence in Melanomas Cancer Res., March 15, 2005; 65(6): 2260 - 2268. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. von Felbert, F. Cordoba, J. Weissenberger, C. Vallan, M. Kato, I. Nakashima, L. R. Braathen, and J. Weis Interleukin-6 Gene Ablation in a Transgenic Mouse Model of Malignant Skin Melanoma Am. J. Pathol., March 1, 2005; 166(3): 831 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
Vet. Pathol., November 1, 2004; 41(6): 712 - 712. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |